The “Artificial Intelligence in Healthcare Market Growth (Status and Outlook) 2022-2029” Study has been added to Data Bridge Market Research’s repository.
The “Artificial Intelligence in Healthcare Market Growth (Status and Outlook) 2022-2029” Study has been added to Data Bridge Market Research’s repository. The world class Artificial Intelligence in Healthcare report endows with the key information about the healthcare industry, including very important facts and figures, expert opinions, and the latest developments across the world. This global market report also identifies and analyses the up-and-coming trends along with major drivers, challenges and opportunities in the healthcare industry. For the same, analysis on vendors, geographical regions, types, and applications has been carried out. In this report, market is segmented based on mainly type, application, and region. This enables the buyer of the report to achieve a telescopic view of the competitive landscape and plan the business strategies accordingly to thrive in the market.
Data Bridge Market Research analyses that the artificial intelligence in healthcare market is expected to undergo a CAGR of 51.37% during the forecast period of 2022-2029. This indicates that the market value, which was USD 6.35 billion in 2021, would rocket up to USD 175.22 billion by 2029. “Patients” dominates the end user segment of the artificial intelligence in healthcare market owing to the increasing product launches, availability of the larger patient pool, high resource availability, high penetration of high speed internet and advancements in healthcare technologies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download Sample Copy of Artificial intelligence in healthcare Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-in-healthcare-market
Recent developments
- In January 2019, Dartford and Gravesham NHS Trust in the United Kingdom came up with an AI-powered wearable technology for patient monitoring when they are discharged from the hospitals.
- In October 2019, care.ai and NVIDIA announced a collaboration to provide an artificial intelligence-powered autonomous patient monitoring in healthcare leveraging NVIDIA’S platform.
- In March 2020, care.ai formed a partnership with the Texas Hospital Association (THA) for creating statewide adoption of AI for autonomous monitoring.
Competitive Landscape and Artificial Intelligence in Healthcare Market Share Analysis
- NVIDIA Corporation (US),
- Intel Corporation (US),
- IBM (US),
- Google LLC (US),
- Microsoft (US),
- General Vision Inc. (US),
- Johnson & Johnson Services, Inc. (US),
- Siemens Healthcare GmbH (Germany),
- Medtronic (Ireland),
- CloudMedx Inc. (US),
- Agfa-Gevaert Group (Belgium),
- Oncora Medical (US),
- Imagia Cybernetics Inc. (Canada),
- Micron Technology, Inc. (US),
- DeepMind Technologies Limited (UK),
- Welcome AI (US)
Artificial Intelligence in Healthcare Market Regional Analysis/Insights
The Global Artificial Intelligence In Healthcare Market is analysed and market size insights and trends are provided by country, offering, technology, application and end user as referenced above.
The countries covered in the artificial intelligence in healthcare market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the artificial intelligence in healthcare market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, high healthcare spending combined with the onset of Covid-19 pandemic and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, ever-rising geriatric population base and the growing demand for quality healthcare in the region.
To Read More, Visit @ https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-in-healthcare-market
Artificial Intelligence in Healthcare Market Dynamics
Drivers
- The rise in the prevalence of disorders
Surging prevalence of chronic and acute disorders and diseases all around the globe owing to various internal and external factors is one of the major factors responsible for fostering growth of the market. Rising patient pool especially in the developing economies is carving the way for the growth of the market.
- Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies have led to the advancements in the medical technology and have improved the quality of healthcare facilities.
- Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the growth of the market. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative personal health devices market growth opportunities.
Additionally, surge in the personal disposable income level, introduction of technologically driven product in hospitals and increasing investment for the development of advanced, growing demand for robotically assisted surgeries, rising adoption of minimally invasive devices and innovative technology, positively affect the market growth rate.
Opportunities
Furthermore, upsurge in the public-private funding for target research activities, increasing need for improvised healthcare services owing to imbalance between health workforce and patients and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, rising geriatric population base, rising number of cross-industry partnerships and collaborations and increasing per capita expenditure on health care will further expand the market’s growth rate in the future.
Restraints/Challenges
On the other hand, high cost associated with the research and development proficiencies, reluctance among medical practitioners to adopt artificial intelligence-based technologies and clinical risks and difficulties related with the medical procedures are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, lack of curated healthcare data, concerns related to data privacy, lack of interoperability and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
Artificial Intelligence in Healthcare Market Objectives:
1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Artificial Intelligence in Healthcare Market
2 To analyze and forecast the size of the Artificial Intelligence in Healthcare Market, in terms of value and volume
3 To analyze opportunities in the Artificial Intelligence in Healthcare Market for stakeholders and provide a competitive landscape of the market
4 To define, segment, and estimate the Artificial Intelligence in Healthcare Market based on deposit type and end-use industry
5 To strategically profile key players and comprehensively analyze their market shares and core competencies
6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market
7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America
8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Artificial Intelligence in Healthcare Market
Segmentation:- Artificial Intelligence in Healthcare Market
Offering
- Hardware
- Software
- Services
Technology
- Machine Learning
- Natural Language Processing
- Context- Aware Computing
- Computer Vision
Application
- Robot-assisted Surgery
- Virtual Assistants
- Administrative Workflow Assistants
- Connected Machines
- Diagnosis
- Clinical Trials
- Fraud Detection
- Cyber security
- Dosage Error Reduction
End user
- Patients
- Pharmaceuticals and Biotechnology Companies
- Healthcare Payers
- Others
Table Of Contents: Global Artificial Intelligence in Healthcare market
1 Introduction
2 Market Segmentation
3 Market Overview
4 Executive Summary
5 Premium Insights
6 Global Artificial Intelligence in Healthcare market, By Type
7 Global Artificial Intelligence in Healthcare market, By Tumor Type
8 Global Artificial Intelligence in Healthcare market, By Application
9 Global Artificial Intelligence in Healthcare market, By End User
0 Global Artificial Intelligence in Healthcare market, By Geography
11 Global Artificial Intelligence in Healthcare market, Company Landscape
12 Company Profiles
13 Related Reports
Get In-depth Table of Content At https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-intelligence-in-healthcare-market
Related Reports:
Seasonal Affective Disorder Market, By Type (Fall & Winter SAD, Spring & Summer SAD, Others), Physical Exam (Lab Tests, Psychological Evaluation, Others), Treatments (Light Therapy, Medications, Psychotherapy, Counselling, Others), End Use (Hospitals, Clinics, Research Institutes, Others): https://www.databridgemarketresearch.com/reports/global-seasonal-affective-disorder-market
3D Cell Culture Market, By Product (Scaffold-Based, Scaffold-Free, Microfluidics-Based, Magnetic Levitation and 3D Bio-printing), Type (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer and Stem Cell Research, Drug Discovery and Toxicology Testing, Tissue Engineering and Regenerative Medicine), End User (Pharmaceutical and Biotechnology Companies, Academic, Institutes, Research Laboratories): https://www.databridgemarketresearch.com/reports/global-3d-cell-culture-market
Health Tourism Market, By Service Type (Transport, Accommodation, Hospitality, Others), Type of Treatment (Cardiovascular Treatment, Orthopedic Treatment, Dental Treatment, Fertility Treatment, Cosmetic Treatment, Neurological Treatment, Cancer Treatment, Others) https://www.databridgemarketresearch.com/reports/global-health-tourism-market
Hemoglobinopathies Market, By Indication (Sickle Cell Disease, Beta Thalassemia and Alpha Thalassemia), End User (Hospitals, Diagnostics Laboratories and Clinics), Test Type (Routine Red Blood Cell (RBC) Count, Genetic Testing, Haemoglobin by High Performance Liquid Chromatography, Haemoglobin Isoelectric Focusing (Hb IEF), Haemoglobin electrophoresis (Hb ELP) and Haemoglobin Solubility Test), Pipeline Therapeutics (NiCord, ZFP Transcription Factors, ALN-TMP, Drug Targeting PRMT5 and Drug Targeting Protein Arginine Methyltransferase 5), https://www.databridgemarketresearch.com/reports/global-hemoglobinopathies-market
Avian Influenza Drug Market, By Strain Type (H5N1, H5N6, H6N1, H7N4, H7N9, H9N2, H10N8), Treatment Type (Neuraminidase Inhibitors, Viral Vaccines), Route of Administration (Oral, Injectable), Application (Chicken, Turkey, Goose and Duck), Distribution Channel Type (Online Pharmacy, Direct Tenders, Retailers, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others): https://www.databridgemarketresearch.com/reports/global-avian-influenza-drug-market
Emphysema Drug Market – Industry Trends and Forecast to 2028: https://www.databridgemarketresearch.com/reports/global-emphysema-drug-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475